菌血症(Bacteremia):治療薬開発パイプライン動向2014

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DELVE41017067)
◆英語タイトル:Bacteremia-Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DELVE41017067
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:60以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[菌血症(Bacteremia):治療薬開発パイプライン動向2014]についてメールでお問い合わせはこちら
本調査レポートでは、世界における菌血症(Bacteremia)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の製品リスト等をお届けしています。また、菌血症(Bacteremia)治療薬開発に取り組んでいる企業情報も提供しています。(※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。)

・菌血症(Bacteremia)の概要

・菌血症(Bacteremia)のパイプライン製品概要

・企業別開発中の治療薬

・後期治験段階の製品(Filed & Phase III):比較分析

・中期治験段階の製品(Phase II):比較分析

・初期治験段階の製品(Phase I & IND):比較分析

・前臨床段階の製品:比較分析

・薬剤候補のプロファイル

・菌血症(Bacteremia)治療薬の評価
  - 単剤治療薬
  - 併用治療薬
  - 投与経路別
  - 分子の種類別

・開発が中止された製品リスト

・開発休止中の製品リスト

・菌血症(Bacteremia)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s,“ Bacteremia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Bacteremia. This report provides information on the therapeutic development based on the Bacteremia dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of Bacteremia
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Bacteremia pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Bacteremia and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
• Complete Pipeline intelligence and complete understanding over therapeutics development for Bacteremia
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Bacteremia pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions


*** レポート目次(コンテンツ)***

Table of Contents
• Bacteremia Overview
• Bacteremia Pipeline Therapeutics
• Bacteremia Therapeutics under Development by Companies
• Bacteremia Late Stage Products (Filed and Phase III)
– Comparative Analysis
• Bacteremia Mid Clinical Stage Products (Phase II)
– Comparative Analysis
• Bacteremia Early Clinical Stage Products (Phase I and IND Filed)
– Comparative Analysis
• Bacteremia Discovery and Pre-Clinical Stage Products
– Comparative Analysis
• Drug Candidate Profiles
• Bacteremia – Therapeutics Assessment
– Assessment by Monotherapy Products
– Assessment by Combination Products
– Assessment by Route of Administration
– Assessment by Molecule Type
• Bacteremia – Discontinued Products
• Bacteremia – Dormant Products
• Companies Involved in Therapeutics Development for Bacteremia
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Bacteremia, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• Bacteremia Assessment by Monotherapy Products
• Bacteremia Assessment by Combination Products
• Bacteremia Assessment by Route of Administration
• Bacteremia Assessment by Stage and Route of Administration
• Bacteremia Assessment by Molecule Type
• Bacteremia Assessment by Stage and Molecule Type
• Bacteremia Therapeutics – Discontinued Products
• Bacteremia Therapeutics – Dormant Products
• Products under Development by Companies, 2014


List of Figures
• Number of Products under Development for Bacteremia, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• Bacteremia Assessment by Monotherapy Products
• Bacteremia Assessment by Combination Products
• Bacteremia Assessment by Route of Administration
• Bacteremia Assessment by Stage and Route of Administration
• Bacteremia Assessment by Molecule Type
• Bacteremia Assessment by Stage and Molecule Type


*** レポートのキーワード ***

菌血症(Bacteremia)、治療薬(医薬品、薬剤)、製薬企業、研究開発、治験、製品パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界の空気バネ市場2017
    Notes:Sales, means the sales volume of Air Spring Revenue, means the sales value of Air Spring This report studies sales (consumption) of Air Spring in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue a …
  • 世界のブラッシャー(頬紅)市場2016
    Notes:Production, means the output of Blusher Revenue, means the sales value of Blusher This report studies Blusher in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market …
  • 医薬品有効成分の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2021)
    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the in …
  • 組み立てワークステーションの世界市場2016
    The Global Assembly Workstation Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Assembly Workstation industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain s …
  • ドイツの肥満外科処置動向(~2020)
    Germany Bariatric Surgery Procedures Outlook to 2020 Summary GlobalData’s new report, "Germany Bariatric Surgery Procedures Outlook to 2020", provides key market data on the Germany Bariatric Surgery Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures …
  • 世界の酵母細胞壁エキス市場:詳細分析レポート2017-2022
    This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Yeast Cell Wall Extract industry. This report splits Yeast Cell W …
  • 世界のレボセチリジン市場2017
    Levocetirizine Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany …
  • 世界のビデ市場2017
    Notes:Sales, means the sales volume of Bidets Revenue, means the sales value of Bidets This report studies sales (consumption) of Bidets in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market sh …
  • 世界及び中国のスチレン系共重合体市場2017
    The 'Global and Chinese Styrenic copolymer Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Styrenic copolymer industry with a focus on the Chinese market. The report provides key statistics on the market status of the Styrenic copol …
  • Risperdal Consta LP:医薬品の世界市場2016
    DelveInsight Drug Report, “Risperdal Consta LP- Drug Insights, 2016” highlights the Risperdal Consta LP marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers the Global Market Assessment of the Risperdal Consta LP covering the to …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DELVE41017067 )"菌血症(Bacteremia):治療薬開発パイプライン動向2014" (英文:Bacteremia-Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。